RxSight (RXST) Current Assets (2020 - 2026)

RxSight (RXST) has reported Current Assets for 7 consecutive years, with $327.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 15.33% year-over-year to $327.4 million; the trailing twelve-month figure through Jun 2026 stood at $327.4 million (up 15.33% YoY), and the FY2025 full-year result was $287.5 million, down 2.17% from the prior year.
• Current Assets climbed to $327.4 million in Q2 2026 per RXST's latest filing, from $279.2 million in the prior quarter.
• Across five years, Current Assets topped out at $327.4 million in Q2 2026 and bottomed at $134.6 million in Q4 2022.
• Historically, Current Assets has averaged $226.1 million across 5 years, with a median of $233.4 million in 2023.
• The widest YoY moves for Current Assets: up 98.46% in 2022, down 25.32% in 2022.
• Over 5 years, Current Assets stood at $134.6 million in 2022, then increased by 25.16% to $168.4 million in 2023, then soared by 74.47% to $293.8 million in 2024, then dropped by 2.17% to $287.5 million in 2025, then gained by 13.89% to $327.4 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $327.4 million, $279.2 million, and $287.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.